Femoral Nerve Gliding Versus Lumbopelvic Manipulation in Management of Patellofemoral Pain Syndrome

July 16, 2026 updated by: Marihan Aziz Zakaria

The present study is the first one to compare the effectiveness of adding (FNG) versus (LPM ) to conventional exercise therapy in pain, knee functional abilities, hip extension ROM and femoral nerve electrophysiological studies among those with PFPS.

This study will be conducted at the outpatient clinic of faculty of Physical Therapy, Cairo University Sixty patients with unilateral PFPS referred from an orthopaedic surgeon for selection criteria, will be included in the study. Measurement procedures, treatment procedures, and the study's goal will be explained to each patient before participation in the study. After being informed about the study aim, they will be asked to sign an informed consent for their approval to participate

The study patients will be randomly assigned into three groups

  • Group A: control group will receive conventional hip-knee focused exercises only.
  • Group B: study group will receive FNG in addition to the same conventional hip-knee focused exercises.
  • Group C: study group will receive LPM in addition to the same hip-knee focused exercises All patients will receive 2 sessions/week for 6 weeks (12 sessions). They will be instructed to do the conventional hip-knee exercises at least two times per day. Each session will last for 20-30 minutes.

Patients diagnosed with unilateral PFPS will be screened based on the following inclusion and exclusion criteria A sample size of 60 participants will be appropriate. The computations will done using G* Power version 3.1.9.2 (Franz Faul, Uni Kiel, Germany) Randomization and blinding will be accomplished through using selected types such as A 1:1:1 allocation ratio will be employed for randomization using the website http://www.randomization.com. Blinding will be done on the patients, assessor, and statistician. All patients will be blinded to the task assigned to their group by ensuring they will be unaware of the exercises that the other group will complete. To maintain blinding, the intervention sessions will be administered to each member of the treatment group separately. Before the trial began, an impartial research assistant who will not participating in the study and he will keep the allocation sequence a secret. It will be kept hidden in opaque, sealed envelopes that will not be opened until baseline data will be collected

Outcome Measures:

  1. Knee Pain
  2. Knee function
  3. Electro-physiological studies including (sensory nerve conduction velocity and distal latency).
  4. Sagittal plane hip extension range of motion as a reference for femoral nerve mechanosensitivity changes - The outcomes will be measured at baseline (pre-test) and after 12sessions (after 6 weeks) (post-test) Then patients will receive 4 types of assessments step's including pain assessment using NRS then knee function assessment using arabic version of AKPS then hip extension ROM assessment using digital goniometer after that the electrophysiological studies including femoral nerve will be conducted using the computerized electromyography device for measuring selective parameters such nerve conduction velocity and its amplitude along with onset and peak latency.

Then Intervention will be completed as follow : All patients will receive two treatment session per week for six weeks (6 sessions), supervised by primary investigator. Separate sessions will be given to each treatment group's members. Each session lasted for 15-30 minutes. The three groups will receive hip-knee focused exercises approved by the clinical practice guidelines linked to the international classification of functioning, disability, and health from the Academy of Orthopedic Physical Therapy of the American Physical Therapy Association which consisted of hamstring/calf and ilio-tibial band stretching and hip/knee strengthening exercises. group B will receive FNG addition to hip-knee focused exercises. group C will receive LPM in addition to hip-knee focused exercise. The session of the control group will start with stretching exercises followed by strengthening exercises. On the other hand, the study group session will start with stretching exercises followed by femoral nerve glide and/or LPM then strengthening ex.

The study has a 3 null hypothesis

  1. There will be no statistically significant effects of adding FNG to conventional exercises in patients with PFPS on:

    A) Knee pain. B) Functional abilities. C) Hip extension ROM. D) Electrophysiological study (NCV and distal latency).

  2. There will be no statistically significant effects of adding LPM to conventional exercises in patients with PFPS on:

    A) Knee pain. B) Functional abilities. C) Hip extension ROM. D) Electrophysiological study (NCV and distal latency).

  3. There will be no statistically significant difference between adding FNG versus LPM to conventional exercises in patients with PFPS on:

A) Knee pain. B) Functional abilities.C) Hip extension ROM. D) Electrophysiological study (NCV and distal latency).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Ramez Fady Fahim, Master degree of orthopedic PT
  • Phone Number: 0201288141231 0201211553069
  • Email: Ramezfahim1993@gmail.com

Study Locations

      • Cairo, Egypt
        • Faculty of physical therapy-Cairo University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age of the subjects is between 18-35 years.
  • BMI will be from 18.5 to ≤ 29.5 Kg/m2
  • Anterior or retro patellar knee pain either on the dominant or non- dominant leg for at least 6 weeks duration .
  • Worst pain level in the previous month of up to 3cm on a 10cm numerical rating scale (NRS)
  • Per or retropatellar pain during at least 2 of the following activities: squatting, prolonged sitting, kneeling, running, jumping and climbing stairs
  • Showing 2 or more positive signs on the following clinical tests: Clarke's sign, Waldron test, active patellar grind test, patellar compression test, and palpation of the medial/lateral articular border of the patella .
  • Patients had positive femoral slump test with limited active lumber ROM.

Exclusion Criteria:

  • History of previous knee surgery and any knee pathology (meniscus tear, patellar tendinopathy, ligament sprain and osteoarthritis) .
  • Any systemic diseases and/or connective tissue disorders .
  • Bursitis and ligament tears .
  • Lower back dysfunction such as disc lesion, sciatica or spondylolisthesis.
  • participants that had undergone physiotherapy during the preceding 3 month.
  • Pregnant women.
  • Osteoporosis or recent fracture of the hip or spinal joints.• . Radiographic evidence or medical diagnosis of spinal instability (Grade II spondylolithesis or greater), spondyloarthritides, or severe spinal misalignment
  • Nervous system disease or disorder
  • .Lumbosacral nerve root compression (any of the following signs present) a. Positive straight leg raise (SLR) test less than 45°, marked paresis (<3/5 on manual muscle testing) involving a major muscle group of the lower extremity, diminished, and asymmetric (lower than uninvolved side), lower extremity muscle stretch reflex and diminished or absent sensation to pinprick in any lower extremity dermatome (D'Agati M 2022).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: group C will receive LPM in addition to hip-knee focused exercise.

Group C will start with stretching exercises for hamstrings ,calf & the iliotibial band, and then they will receive LPM.

Lumbopelvic manipulation consists of applying rotational glide forces to the ipsilateral lumbopelvic region of the involved knee. and the therapist stood contralateral to the side which was to be manipulated. They will passively move onto their side, toward the side to be manipulated, and then interlock their fingers behind their head. The researcher will passively rotate the patient and then deliver a quick thrust to the anterior superior iliac spine in a posterior and inferior direction. Each patient received a maximum of two manipulations on the same side as the symptomatic knee. and then will receive the hip knee strengthening exercises

Patients if group C will receive lumbopelvic manipulation, which consists of applying rotational glide forces to the ipsilateral lumbopelvic region of the involved knee. Patients will lay supine and the therapist stood contralateral to the side which was to be manipulated. They will passively move onto their side, toward the side to be manipulated, and then interlocked their fingers behind their head. The researcher will passively rotate the patient, and then delivered a quick thrust to the anterior superior iliac spine in a posterior and inferior direction. Each patient received a maximum of two manipulations on the same side as the symptomatic knee
For control group (A) will start with the stretching exercises then starting with the hip extensors, then the hip abductors, and finally the hip external rotators. Next, knee strengthening exercises will be carried out, beginning with mini wall squats using a theraband around the distal thigh, followed by terminal knee extension exercise from a standing position, and finishing with seated knee extension exercise from 90° to 45° knee flexion.
Experimental: Group B Patients will receive femoral nerve gliding in addition to exercises
The patients only of group B will positioned on their asymptomatic side with their body in full flexion. The researcher then extended the patient's hip while keeping the knee flexed, holding the position for 2 seconds.when the patient reports soreness or pain. This mobilization technique will be repeated for 3 sets of 10 repetitions per session, with a total of 12 sessions over 6 weeks
For control group (A) will start with the stretching exercises then starting with the hip extensors, then the hip abductors, and finally the hip external rotators. Next, knee strengthening exercises will be carried out, beginning with mini wall squats using a theraband around the distal thigh, followed by terminal knee extension exercise from a standing position, and finishing with seated knee extension exercise from 90° to 45° knee flexion.
The patients only of group B will be positioned on their asymptomatic side with their body in full flexion. The researcher then extended the patient's hip while keeping the knee flexed, holding the position for 2 seconds. when the patient reports soreness or pain. This mobilization technique will be repeated for 3 sets of 10 repetitions per session, with a total of 12 sessions over 6 wks
Other Names:
  • Neural mobilization
Active Comparator: Group A control group will receive exercises only
Group A is a control group will receive only stretching exercises for hamstrings, calf& iliotibial band and then hip knee strengthening exercises
For control group (A) will start with the stretching exercises then starting with the hip extensors, then the hip abductors, and finally the hip external rotators. Next, knee strengthening exercises will be carried out, beginning with mini wall squats using a theraband around the distal thigh, followed by terminal knee extension exercise from a standing position, and finishing with seated knee extension exercise from 90° to 45° knee flexion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
knee pain intensity
Time Frame: 6 weeks
Pain intensity will be measured by the Arabic version of the Numeric Rating Scale during the last 24 hours. The minimum is zero and the maximum highest pain score is 10. The assessment will be done at baseline and after the last treatment session after 6 weeks
6 weeks
functional disability
Time Frame: 6 weeks
functional disability will be measured by the Arabic version of Kujala anterior knee pain questionnaire; higher scores means higher disability
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
femoral nerve conduction velocity by surface electromyography (sEMG).
Time Frame: 6 weeks
Femoral nerve conduction velocity and its distal latency will be measured by surface electromyography (sEMG).
6 weeks
Hip extension Rang of motion
Time Frame: 6 weeks
Hip extension ROM will be assessed before and after the treatment in all groups using digital goniometer
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ramez Fady Fahim, Msc orthopedic PT, Cairo University
  • Study Director: Marihan Zakaria Aziz, PhD orthopedic physical therap, Faculty of physical therapy-cairo university ( department of physical therapy for musculoskeletal disorders and its surgeries)
  • Study Director: Alshaymaa Shaaban Abdelazeim, PhD in physical therapy, Faculty of physical therapy-cairo university ( department of basic science)
  • Study Director: Enas Fawzy Youssif, PhD physical therapy, Faculty of physical therapy-cairo university ( department of physical therapy for musculoskeletal disorders and its surgeries)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

April 1, 2027

Study Registration Dates

First Submitted

July 11, 2026

First Submitted That Met QC Criteria

July 16, 2026

First Posted (Actual)

July 17, 2026

Study Record Updates

Last Update Posted (Actual)

July 17, 2026

Last Update Submitted That Met QC Criteria

July 16, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • NO:P.T.REC/012/006289 6/1/2026

Plan for Individual participant data (IPD)

Study Data/Documents

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patello Femoral Pain Syndrome

Clinical Trials on Lumbopelvic manipulation

3
Subscribe